Prospective risk-adjusted [18F]fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer

Journal of Clinical Oncology

Volumn 27, Issue 15, 2009, Pages 2509-2515

  Moeller, Benjamin J ^a   Rana, Vishal ^a   Cannon, Blake A ^a   Williams, Michelle D ^a   Sturgis, Erich M ^a   Ginsberg, Lawrence E ^a   Macapinlac, Homer A ^a   Lee, J Jack ^a   Ang, K Kian ^a   Chao, K S Clifford ^a   Chronowski, Gregory M ^a   Frank, Steven J ^a   Morrison, William H ^a   Rosenthal, David I ^a   Weber, Randal S ^a   Garden, Adam S ^a   Lippman, Scott M ^a   Schwartz, David L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; INTERMETHOD COMPARISON; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIATION RESPONSE; WART VIRUS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK TUMOR; METHODOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; RADIOGRAPHY; ROC CURVE; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 66349107938     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.19.3300     Document Type: Article

References (32)

1. Denis F, Garaud P, Bardet E, et al: Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22:69-76, 2004 (Pubitemid 41095116)
2. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567-578, 2006 (Pubitemid 43209104)
3. Jeremic B, Shibamoto Y, Milicic B, et al: Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 18:1458-1464, 2000 (Pubitemid 30205391)
4. Clayman GL, Johnson CJ 2nd, Morrison W, et al: The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 127:135-139, 2001
5. Davidson BJ, Newkirk KA, Harter KW, et al: Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 125: 401-405, 1999
6. Sassler AM, Esclamado RM, Wolf GT: Surgery after organ preservation therapy: Analysis of wound complications. Arch Otolaryngol Head Neck Surg 121:162-165, 1995
7. Lavertu P, Bonafede JP, Adelstein DJ, et al: Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 124:401-406, 1998 (Pubitemid 28178310)
8. Pellitteri PK, Ferlito A, Rinaldo A, et al: Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all? Head Neck 28:166-175, 2006
9. McHam SA, Adelstein DJ, Rybicki LA, et al: Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 25:791-798, 2003
10. Peters LJ, Weber RS, Morrison WH, et al: Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 18:552-559, 1996 (Pubitemid 26349535)
11. Velázquez RA, McGuff HS, Sycamore D, et al: The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 130:74-77, 2004 (Pubitemid 38095433)
12. Ojiri H, Mendenhall WM, Stringer SP, et al: Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys 52:420-428, 2002 (Pubitemid 34173003)
13. Chen AY, Vilaseca I, Hudgins PA, et al: PET-CT vs contrast-enhanced CT: What is the role for each after chemoradiation for advanced oropharyngeal cancer? Head Neck 28:487-495, 2006
14. Connell CA, Corry J, Milner AD, et al: Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma. Head Neck 29:986-995, 2007
15. Gourin CG, Williams HT, Seabolt WN, et al: Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 116:705-710, 2006
16. Kubota K, Yokoyama J, Yamaguchi K, et al: FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: Comparison with MRI/CT. Eur J Nucl Med Mol Imaging 31:590-595, 2004 (Pubitemid 38461575)
17. Nayak JV, Walvekar RR, Andrade RS, et al: Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: The utility of PET-CT. Laryngoscope 117:2129-2134, 2007
18. Porceddu SV, Jarmolowski E, Hicks RJ, et al: Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 27:175-181, 2005 (Pubitemid 40315765)
19. Rogers JW, Greven KM, McGuirt WF, et al: Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 58:694-697, 2004
20. Ware RE, Matthews JP, Hicks RJ, et al: Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck. Head Neck 26:1008-1017, 2004
21. Wong RJ, Lin DT, Schoder H, et al: Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20:4199-4208, 2002 (Pubitemid 35191022)
22. Yao M, Luo P, Hoffman HT, et al: Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment. Am J Clin Oncol 30:264-270, 2007 (Pubitemid 46884146)
23. Hashibe M, Brennan P, Benhamou S, et al: Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 99:777-789, 2007 (Pubitemid 47073524)
24. Dabaja B, Salehpour MR, Rosen I, et al: Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: Comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys 63:1000-1005, 2005 (Pubitemid 41505275)
25. Garden AS, Morrison WH, Wong PF, et al: Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 67:438-444, 2007
26. Greven KM, Williams DW 3rd, McGuirt WF Sr, et al: Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23:942-946, 2001
27. Brkovich VS, Miller FR, Karnad AB, et al: The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope 116:855-858, 2006 (Pubitemid 44317978)
28. Gillison ML, D'Souza G, Westra W, et al: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100:407-420, 2008
29. Fakhry C, Westra WH, Li S, et al: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269, 2008
30. Ragin CC, Taioli E: Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis. Int J Cancer 121:1813-1820, 2007
31. Yao M, Smith RB, Graham MM, et al: The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 63:991-999, 2005 (Pubitemid 41505274)
32. Andrade RS, Heron DE, Degirmenci B, et al: Posttreatment assessment of response using FDGPET/ CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 65:1315-1322, 2006 (Pubitemid 44425218)